We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
INS.LSE

Price
-
Stock movement up
+- (%)
Company name
Instem PLC
Exchange
(LSE
,
Currency
GBX
)
Sector
Healthcare >
Health Information Services
Market cap
19.96B
Ent value
19.98B
Price/Sales
-
Price/Book
365.37
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
21.01
PEG
-
EPS growth
23.98%
1 year return
21.61%
3 year return
24.03%
5 year return
26.03%
10 year return
17.79%
Last updated: 2024-12-17

DIVIDENDS

INS.LSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF23080.14
Price to FCF26869.88
Price to EBITDA5038.95
EV to EBITDA5044.14

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book365.37
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count24.05M
EPS (TTM)-
FCF per share (TTM)0.03

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)0.00
Operating income (TTM)0.00
Net income (TTM)0.00
EPS (TTM)-
EPS (1y forward)39.50

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash8.44M
Net receivables15.35M
Total current assets24.17M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment1.45M
Total assets83.65M
Accounts payable4.59M
Short/Current long term debt2.05M
Total current liabilities25.50M
Total liabilities29.01M
Shareholder's equity54.64M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)865.00K
Capital expenditures (TTM)122.00K
Free cash flow (TTM)743.00K
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital1.32%

STOCK INFORMATION

Downside potential

Loading...
Downside potential data
INS.LSES&P500
Current price drop from All-time high-8.29%-4.91%
Highest price drop-66.08%-56.47%
Date of highest drop27 Dec 20129 Mar 2009
Avg drop from high-20.99%-11.07%
Avg time to new high27 days12 days
Max time to new high1058 days1805 days
COMPANY DETAILS
INS.LSE (Instem PLC) company logo
Marketcap
19.96B
Marketcap category
Large-cap
Description
Instem plc, together with its subsidiaries, provides information technology solutions and services to the life sciences healthcare market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include ALPHADAS, an eSource system for early phase clinical trials; BioRails for discovery data management; Comet Assay IV, a live video imaging system for reproducible comet slide scoring; and Cyto Study Manager, a data acquisition and reporting solution. The company also offers computational toxicology products and services; Blur Clinical Annonymization; Logbook ELN, a repository for information; Morphit for discovery data visualization; NOTOCORD-hem software platforms to acquire, display, and analyze physiological signals; and Provantis, a windows-based system for non-clinical evaluation studies. In addition, it provides Samarind RMS to manage medical product information; submit platform that offers tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; SENDView, an application that simplifies the review of SEND datasets; KnowledgeScan Target Safety Assessment services; SENDTrial, a web based solution that can be accessed through a subscription; and Predict delivers computational models. Further, the company provides Sorcerer Colony Counter; sales and administrative support; training, validation, consultancy, cloud, and safety assessment and regulatory information management software services; software solutions to extract intelligence from research and development related healthcare data; and holds intellectual property rights and investment. It also develops, manufactures, and supplies software and hardware products for in vitro study data collection and management. Instem plc was founded in 1969 and is headquartered in Stone, the United Kingdom. As of November 20, 2023, Instem plc was taken p
Employees
500
Investor relations
-
CEO
Country
UK
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found